HSK60002
/ Haisco
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 28, 2026
Phase Ib clinical study of HSK60002 tablets in moderate to severe atopic dermatitis
(chinadrugtrials.org.cn)
- P1 | N=60 | Not yet recruiting | Sponsor: Hisun Pharmaceutical Group Co., Ltd.
New P1 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
1 to 1
Of
1
Go to page
1